N. Hayashi et al., ESTROGEN-INDUCED CELL-TRANSFORMATION AND DNA ADDUCT FORMATION IN CULTURED SYRIAN-HAMSTER EMBRYO CELLS, Molecular carcinogenesis, 16(3), 1996, pp. 149-156
To study the possible involvement of DNA damage in cell transformation
induced by estrogens, we examined whether DNA adduct formation is eli
cited in cultured Syrian hamster embryo (SHE) cells treated with estro
gens and their derivatives by means of the P-32-postlabeling assay. Mo
rphological transformation of the cells was induced by treatment with
diethylstilbestrol (DES) at 1-10 mu g/mL for 24 h but not by treatment
with its derivatives trans, trans-dienestrol (alpha-DIES) or cis, cis
-dienestrol (beta-DIES) at 1-10 mu g/mL for 24 h. Similarly, DNA adduc
t formation was elicited by exposure of SHE cells to DES at 1-10 mu g/
mL for 24 h but not by either alpha-DIES or beta-DIES. Treatment of SH
E cells with DES at 1-10 mu g/mL for 2 h in the presence of exogenous
metabolic activation with rat liver post-mitochondrial supernatant enh
anced morphological transformation in a dose-dependent manner. Our pre
vious studies have demonstrated that exposure of SHE cells to DES unde
r the same conditions with exogenous metabolic activation induces soma
tic mutations at the Na+/K+ ATPase locus. Therefore, we examined wheth
er with exogenous metabolic activation DES induced DNA adduct formatio
n in SHE cells. DNA adducts were not detected when SHE cells were trea
ted with DES at 1-10 mu g/mL for 2 h in the presence of exogenous meta
bolic activation. Treatment with 17 beta-estradiol (E(2)), 2-hydroxyes
tradiol (2-OH E(2)), or 4-hydroxyestradiol (4-OH E(2)) at 1 mu g/mL fo
r 24 h induced DNA adduct formation in the cells, in parallel with the
induction of cell transformation. The rank order of DNA adduct format
ion was 4-OH E(2) > 2-OH E(2) > E(2). The results indicate that estrog
ens induce DNA adduct formation in cultured SHE cells, but the inducti
on may not be the only mechanism relevant to the initiation of cell tr
ansformation. (C) 1996 Wiley-Liss, Inc.